Cancer risk assessment: Historical perspectives, current issues, and future directions

Drug and Chemical Toxicology

Volumn 19, Issue 3, 1996, Pages 161-185

  Velazquez, Susan F ^a   Schoeny, Rita ^b   Rice, Glenn E ^b   Cogliano, Vincent J ^b  

^a Toxicology Excellence for Risk Assessment   (United States)

^b U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOGEN; PEROXISOME PROLIFERATOR;

BLADDER TUMOR; CANCER RISK; CARCINOGENESIS; CHEMICAL CARCINOGENESIS; DOSE RESPONSE; FUTUROLOGY; HISTORY; HUMAN; KIDNEY TUMOR; LIVER TUMOR; NONHUMAN; REVIEW; RISK ASSESSMENT; THYROID TUMOR;

EID: 0029955389     PISSN: 01480545     EISSN: None     Source Type: Journal    
DOI: 10.3109/01480549608998233     Document Type: Review

References (106)

1. Alden, C. L. (1986). A review of unique male rat hydrocarbon nephropathy, Toxicol. Pathol., 14, 109-111.
2. Ames, B. N. and L. S. Gold (1990). Chemical carcinogens: Too many rodent carcinogens, Proc. Natl. Acad. Sci. USA, 87, 7772-7776.
3. Ames, B. N., F. Lee, and W. Durston, (1973a). An improved bacterial test system for the detection and classification of mutagens and carcinogens, Proc. Natl. Acad. Sci. USA, 70, 782-786.
4. Ames, B. N., W. Durston, E. Yamasaki, and F. Lee (1973b). Carcinogens are mutagens: A simple test system combining liver homogenates for activation and bacteria for detection, Proc. Natl. Acad. Sci. USA, 70, 2281-2285.
5. Armitage, P., and R. Doll (1954). The age distribution of cancer and a multistage theory of carcinogenesis, Br. J. Cancer, 8, 1-12.
6. Armitage, P., and R. Doll (1961). Stochastic models for carcinogenesis. In Proceedings of the Fourth Berkeley Symposium on Mathematical Statistics and Probability, University of California Press, Berkeley, 4, 19-38.
7. Ashby, J., and R. W. Tennant (1988). Chemical structure, Salmonella mutagenicity and extent of carcinogenicity as indicators of genotoxic carcinogenesis among 222 chemicals tested in rodents by the U.S. NCI/NTP, Mutat. Res., 204, 17-115.
8. Bos, J. L., and C. F. van Kreijl (1992). Genes and gene products that regulate proliferation and differentiation: Critical targets in carcinogenesis. In Mechanisms of Carcinogenesis in Risk Identification (H. Vainio, P. N. Magee, D. B. McGregor, and A. J. McMichael, eds.), International Agency for Research on Cancer, Lyon, pp. 57-66.
9. Buchmann, A., R. Bauer-Hofmann, J. Mahr, N. R. Drinkwater, A. Luz, and M. Schwarz (1991). Mutational activation of the c-Ha-ros gene in liver tumors of different rodent strains: Correlation with susceptibility to hepatocarcinogenesis, Proc. Natl. Acad. Sci. USA, 88, 911-915.
10. Butterworth, B. E., and S. R. Eldridge (1992). A decision tree approach for carcinogen risk assessment: Application to 1,4-dichlorobenzene, CIIT Activities, Vol. 12 (11-12), Nov.-Dec., 11 pp.
11. Butterworth, B. E., D. J. Loury, T. Smith-Oliver, and R. C. Cattley (1987). The potential role of chemically induced hyperplasia in the carcinogenic activity of hypolipidemic carcinogens, Toxicol. 2nd. Health, 3, 129-149.
12. 01 study: Introduction, objectives and experimental design, J. Environ. Pathol. Toxicol., 3, 1-7.
13. Carlborg, F. W. (1981). Dose-response functions in carcinogenesis and the Weibull model, Food Cosmet. Toxicol., 19, 255-263.
14. Carr, C. J., and A. C. Kolbye (1991). A critique of the use of the maximum tolerated dose in bioassays to assess cancer risks from chemicals, Regul. Toxicol. Pharmacol., 14, 78-87.
15. Cattley, R. C., T. Smith-Oliver, B. E. Butterworth, and J. A. Popp (1988). Failure of the peroxisome proliferator WY-14,643 to induce unscheduled DNA synthesis in rat hepatocytes following in vivo treatment, Carcinogenesis, 9, 1179-1183.
16. Cattley, R. C., D. S. Marsman, and J. A. Popp (1991). Age-related susceptibility to the carcinogenic effect of the peroxisome proliferator WY-14,643 in rat liver, Carcinogenesis, 12, 469-473.
17. Cattley, R. C., D. S. Marsman, R. B. Conolly, and J. A. Popp (1992). Cell proliferation and promotion in peroxisome proliferator-induced rodent hepatocarcinogenicity, CIIT Activities, Chemical Industry Institute of Toxicology, Research Triangle Park, NC, 12(3), 1-4.
18. Chappel, C. I. (1992). A review and biological risk assessment of sodium saccharin, Regul. Toxicol. Pharmacol., 15, 253-270.
19. 2μ-globulin gene family in the liver of NIH black rats, Endocrinology, 125, 1385-1388.
20. Chhabra, R. S., J. E. Huff, B. S. Schwetz, and J. Selkirk (1990). An overview of prechronic and chronic toxicity/carcinogenicity experimental study designs and criteria used by the National Toxicology Program, Environ. Health Perspect., 86, 313-321.
21. Clayson, D. B. (1975). The chemical induction of cancer. In Biology of Cancer, 2nd ed. (E. J. Ambrose and F. J. C. Roe, eds.), Ellis Horwood, Chichester, pp. 163-179.
22. Clayson, D. B. (1978). Overview, fact, myth and speculation, J. Environ. Pathol. Toxicol., 2, 1-8.
23. Clayson, D. B. (1989). Can a mechanistic rationale be provided for nongenotoxic carcinogens identified in rodent bioassays? Mutat. Res., 221, 53-67.
24. Clayson, D. B., and D. J. Clegg (1991). Classification of carcinogens: Polemics, pedantics, or progress? Regul. Toxicol. Pharmacol., 14, 147-166.
25. Cohen, A. J., and P. Grasso (1981). Review of the hepatic response to hypolipemic drugs in rodents and assessment of its significance to man, Food Cosmet. Toxicol., 19, 585-605.
26. Cohen, S. M., and L. B. Ellwein (1991). Genetic errors, cell proliferation, and carcinogenesis, Cancer Res., 51, 6493-6505.
27. Cohen, S. M., M. Cano, R. A. Earl, S. D. Carson, and E. M. Garland (1991). A proposed role for silicates and protein in the proliferative effects of saccharin on the male rat urothelium, Carcinogensis, 12, 1551-1555.
28. Cornfield, J. (1977). Carcinogenic risk assessment, Science, 198, 693-699.
29. Cornfield, J., F. W. Carlborg, and J. Van Ryzin (1978). Setting tolerance on the basis of mathematical treatment of dose-response data extrapolated to low doses. In Proceedings of First International Congress on Toxicology: Toxicology as a Predictive Science (G. L. Plaa and W. A. M. Duncan, eds.), Academic Press, New York, pp. 143-164.
30. Crump, K. S. (1979). Dose response problems in carcinogenesis, Biometrics, 35, 157-167.
31. Crump, K. S., D. G. Hoel, C. Langley, and R. Peto (1976). Fundamental carcinogenic processes and their implications for low dose risk assessment, Cancer Res., 36, 2973-2979.
32. Davidson, I. W. F., J. C. Parker, and R. P. Beliles (1986). Biological basis for extrapolation across mammalian species, Regul. Toxicol. Pharmacol., 6, 211-237.
33. Dent, J. N., E. L. Godsden, and J. Furth (1956). Further studies on induction and growth of thyrotropic pituitary tumors in mice, Cancer Res., 16, 171-174.
34. Dodson, A. T. (1970). Urological Surgery, 4th ed., C. V. Mosby, St. Louis, 350 pp.
35. Doll, R. (1971). Age distribution of cancer, J. R. Stat. Soc. Ser. A, 134, 133-166.
36. Dragani, T. A., G. Manenti, M. Gariboldi, F. S. Falvella, M. A. Pierotti, and G. Della Porta (1992). Genetics of hepatocarcinogenesis in mouse and man. In Oncogenes and Transgenic Correlates of Cancer Risk Assessment. NATO ASI Series A, Life Sciences (C. Zervos, ed.), Plenum Publishing, New York, 232, 71-90.
37. Elcock, M., and R. W. Morgan (1993). Update on artificial sweeteners and bladder cancer, Regul. Toxicol. Pharmacol., 17, 35-43.
38. Ellwein, L. B., and S. M. Cohen (1990). The health risks of saccharin revisited, Crit. Rev. Toxicol., 20, 311-326.
39. Fearon, E. R., and B. Vogelstein (1990). A genetic model for colorectal tumorigenesis, Cell, 61, 759-767.
40. Fisher, R. A. (1932). Statistical Methods for Research Workers, 4th ed., Oliver & Boyd, London.
41. Flamm, W. G., and L. D. Lehman-McKeeman (1991). The human relevance of the renal tumor-inducing potential of d-limonene in male rats: Implications for risk assessment, Regul. Toxicol. Pharmacol., 13, 70-86.
42. Gariboldi, M., G. Manenti, F. Canzian, F. S. Falvella, M. A. Pierotti, G. D. Porta, G. Binelli, and T. A. Dragani (1993). Chromosome mapping of murine susceptibility loci to liver carcinogenesis, Cancer Res., 53, 209-211.
43. Garland, E. M., T. Sakata, M. J. Fisher, T. Masui, and S. M. Cohen (1989). Influences of diet and strain on the proliferative effect on the rat urinary bladder induced by sodium saccharin, Cancer Res., 49, 3789-3794.
44. 01 Study) (J. A. Staffa, and M. A. Mehlman, eds.), International Toxicology Books, Kingston, NJ, pp. 179-186.
45. Gibson, G. G. (1993). Peroxisome proliferators: Paradigms and prospects, Toxicol. Lett., 68, 193-201.
46. Green, T., J. Odum, J. A. Nash, and J. R. Foster (1990). Perchloroethylene-induced rat kidney tumors: An investigation of the mechanisms involved and their relevance to humans, Toxicol. Appl. Pharmacol., 102, 77-89.
47. Hanigan, M. H., M. C. Winkler, and N. R. Drinkwater (1990). Partial hepatectomy is a promoter of hepatocarcinogenesis in C57BL/6J male mice but not in C3H/HeJ male mice, Carcinogenesis, 11, 589-594.
48. Hard, G. C. (1990). Tumors of the kidney, renal pelvis and ureter. In Pathology of Tumors in Laboratory Animals. Vol. 1: Tumors of the Rat, 2nd ed. (V. S. Turuscov and U. Mohr, eds.), International Agency for Research on Cancer, Lyon, IARC Scientific Publication No. 99.
49. Harris, C. C. (1992). Tumour suppressor genes, multistage carcinogenesis and molecular epidemiology. In Mechanisms of Carcinogenesis in Risk Identification (H. Vainio, P. N. Magee, D. B. McGregor, and A. J. McMichael, eds.), International Agency for Research on Cancer, Lyon, pp. 67-86.
50. Haseman, J. K., J. E. Huff, G. N. Rao, J. E. Arnold, G. A. Boorman, and E. E. McConnell (1985). Neoplasms observed in untreated and corn oil gavage control groups of F344/N rats and (C57BL/6N x C3H/HeN)F1 (B6C3F1) mice, JNCI 75, 975-984.
51. Hill, R. N., L. S. Erdreich, O. E. Paynter, P. A. Roberts, S. L. Rosenthal, and C. F. Wilkinson (1989). Review: Thyroid follicular cell carcinogenesis, Fundam. App. Toxicol., 12, 629-697.
52. Hillyard, A. L., D. P. Doolittle, M. T. Davisson, and T. H. Roderick (1992). Locus map of mouse with comparative map points of human on mouse, The Jackson Laboratory, Bar Harbor, ME.
53. Hoel, D. G., D. Gaylor, R. Kirschstein, U. Saffiotti, and M. Schneiderman (1975). Estimation of risks of irreversible delayed toxicity, J. Toxicol. Environ. Health, 1, 133-151.
54. Hoel, D. G., J. K. Haseman, M. D. Hogan, J. Huff, and E. E. McConnel (1988). The impact of toxicity on carcinogenicity: Implications for risk assessment, Carcinogenesis, 9, 2045-2052.
55. Issemann, I., and S. Green (1990). Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators, Nature, 347, 645-650.
56. Jull, J. W. (1979). The effect of time on the incidence of carcinomas obtained by the implantation of paraffin wax pellets in the mouse bladder, Cancer Lett., 6, 21-25.
57. Kennaway, E. L. (1924a). On cancer-producing tars and tar fractions, J. Ind. Hyg., 5, 462-488.
58. Kennaway, E. L. (1924b). On the cancer-producing factor in tar, Br. Med. J., 1, 564-567.
59. Kociba, R. J. (1987). Issues in biochemical applications to risk assessment: How should the MTD be selected? Environ. Health Perspect., 76, 169-174.
60. Mantel, N., and W. R. Bryan (1961). Safety testing of carcinogenic agents, JNCI, 27, 455-470.
61. Maronpot, R. R., J. K. Haseman, G. A. Boomran, S. E. Eustis, G. N. Rao, and J. E. Huff (1987). Liver lesions in B6C3F1 mice: The National Toxicology Program, experience and position. In Mouse Liver Tumors: Proceedings of the European Society of Toxicology, (P. L. Chambers, D. Henschler, F. Oesch, eds.), Arch. Toxicol. Suppl. 10. Springer-Verlag, New York, pp. 10-28.
62. Marsman, D. S., R. C. Cattley, and R. A. Popp (1988). Contrasting effects of di(2-ethylhexyl)phthalate and Wyeth 14,643 on hepatocyte proliferation and carcinogenicity in male F344 rats [abstract], Proc. Am. Assoc. Cancer Res., 29, 87.
63. McConnell, E. E., H. A. Solleveld, J. A. Swenberg, and G. A. Boorman (1986). Guidelines for combining neoplasms for evaluation of rodent carcinogenesis studies, JNCI, 76, 283-289.
64. Miller, E. C., and J. A. Miller (1981). Searches for ultimate chemical carcinogens and their reactions with cellular macromolecules, Cancer, 47, 2327-2345.
65. Moolgavkar, S., and A. Knudson (1981). Mutation and cancer: A model for human carcinogenesis, JNCI, 66, 1037-1052.
66. Munro, I. C., and D. R. Krewski (1981). Risk assessment and regulatory decision making, Food Cosmet. Toxicol., 19, 549-560.
67. [NAS] National Academy of Sciences (1980). The effects of populations of exposure to low levels of ionizing radiation, National Research Council, National Academy of Sciences, Washington, DC.
68. [NCRP] National Council on Radiation Protection (1985). Induction of thyroid cancer by ionizing radiation, NCRP Report 80, National Council on Radiation Protection and Measurement, Bethesda, MD.
69. [NRC] U.S. National Research Council, Commission on Life Sciences, Committee on the Institutional Means for Assessment of Risks to Public Health (1983). Risk Assessment in the Federal Government: Managing the Process, National Academy Press, Washington, DC.
70. [NRC] U.S. National Research Council, Commission on Life Sciences, Committee on Risk Assessment Methodology (1993). Use of the maximum tolerated dose in animal bioassays for carcinogenicity. In Issues in Risk Assessment, National Academy Press, Washington, DC. pp. 14-77.
71. Okamura, T., E. M. Garland, T. Masui, T. Sakata, M. St. John, and S. M. Cohen (1991). Lack of bladder tumor promoting activity in rats fed sodium saccharin in AIN-76A diet, Cancer Res., 51, 1778-1782.
72. Olson, M. J., J. T. Johnson, and C. A. Reidy (1990). A comparison of male rat and human urinary proteins: Implications for human resistance to hyaline droplet nephropathy, Toxicol. Appl. Pharmacol., 102, 524-536.
73. [OSTP] Office of Science and Technology Policy (1985). Chemical carcinogens: Notice of review of the science and its associated principles, Fed. Reg , 50, 10372-10442.
74. Paynter, O. E., G. J. Burin, R. B. Jaeger, and C. A. Gregano (1986). Neoplasia induced by inhibition of thyroid gland function (guidance for analysis and evaluation), Hazard Evaluation Division. U.S. Environmental Protection Agency, Washington, DC.
75. Pitot, H. C. (1981). Fundamentals of Oncology, 2nd ed., revised and expanded. Marcel Dekker, New York, Chaps. 1 and 3.
76. Pott, P. (1775) Chirurgical observations relative to the cancer of the scrotum, London. [Reprinted (orig. 1775) in NCI Monogr. 10, 7-13].
77. Rai, K., and J. Van Ryzin (1981). A generalized multi-hit dose-response model for low-dose extrapolation, Biometrics, 37, 341-352.
78. Ramel, C. (1992). Genotoxic and nongenotoxic carcinogens: Mechanisms of action and testing strategies. In Mechanisms of Carcinogenesis in Risk Identification (H. Vainio, P. N. Magee, D. B. McGregor, and A. J. Michael, eds.), International Agency for Research on Cancer, Lyon, pp. 195-209.
79. Rao, M. S., and J. K. Reddy (1989). The relevance of peroxisome proliferation and cell proliferation in peroxisome proliferator-induced hepatocarcinogenesis, Drug Metab. Rev., 21, 103-110.
80. Rao, M. S., and J. K. Reddy (1991). An overview of peroxisome proliferator-induced hepatocarcinogenesis, Environ. Health Perspect., 93, 205-209.
81. Reddy, J. K., and M. S. Rao (1992). Peroxisome proliferation and hepatocarcinogenesis. In Mechanisms of Carcinogenesis in Risk Identification (H. Vainio, P. N. Magee, D. B. McGregor, and A. J. Michael, eds.), International Agency for Research on Cancer, Lyon, pp. 225-235.
82. Rehn, L. (1895) Blasengeschwiilste bei Fuchsin-Arbeitern, Arch. Klin. Clir., 50, 588-600.
83. 2μ-globulin, Fundam. Appl. Toxicol., 15, 732-743.
84. Roy, A. K., and O. W. Neuhaus (1967). Androgenic control of a sex-dependent protein in the rat, Nature, 214, 618-620.
85. Schaller, R. T., and J. K. Stevenson (1966). Development of carcinoma of the thyroid in iodine deficient mice, Cancer, 19, 1063-1080.
86. Shubik, P., and D. B. Clayson (1976). Application of the results of carcinogen bioassays to man. In Environmental Pollution and Carcinogenic Risks (C. Rosenfeld, W. Davis, eds.), International Agency for Research on Cancer, Scientific Publications, Paris, 13, 241-252.
87. Snedecor, G. W., and W. G. Cochran (1980). Statistical Methods, Iowa State University Press, Ames, IA.
88. Stott, W. T. (1988). Chemically induced proliferation of peroxisomes: Implications for risk assessment, Regul. Toxicol. Pharmacol., 8, 125-159.
89. 1 mice and Fischer 344 rats, Carcinogenesis, 9, 271-276.
90. 2μ-globulin nephropathy, Toxicol. Appl. Pharmacol., 97, 35-46.
91. Tada, M., M. Omata, and M. Ohto (1990). Analysis of ras gene mutations in human hepatic malignant tumors by polymerase chain reaction and direct sequencing, Cancer Res., 50, 1121-1124.
92. Tennant, R. W., M. R. Elwell, J. W. Spalding, and R. A. Griesmer (1991). Evidence that toxic injury is not always associated with induction of chemical Carcinogenesis, Mol. Carcinog., 4, 420-440.
93. Thorslund, T. W., C. C. Brown, and G. Charnley (1987). Biologically motivated cancer risk models, Risk Anal., 7, 109-119.
94. [USEPA] U.S. Environmental Protection Agency (1986). Guidelines for carcinogen risk assessment, Fed. Reg. 51 (33992), 1-17.
95. [USERA] U.S. Environmental Protection Agency (1989). Workshop Report on EPA Guidelines for Carcinogen Risk Assessment, Risk Assessment Forum, Technical Panel on Carcinogen Guidelines, Washington, DC. EPA/625/3-89/015, March.
96. 2μ-globulin: Association with chemically induced renal toxicity and neoplasia in the male rat, Prepared for the Risk Assessment Forum, Washington, DC. EPA/625/3-91/019F, September.
97. 3/4/day; Notice. 57, Fed. Reg., 109, 24252-24173.
98. [USEPA] U.S. Environmental Protection Agency (1993). Integrated Risk Information System (IRIS) [Online], Office of Health and Environmental Assessment, Environmental Criteria and Assessment Office, Cincinnati, OH.
99. van Etten, C. H. (1969). Goitrogens. In Toxic Constituents of Plant Foodstuffs (I. E. Liener, ed.), Academic Press, New York, pp. 103-142.
100. Weinstein, B. (1992). Toxicity, cell proliferation, and carcinogenesis. Mol. Carcinog., 5, 2-2.
101. [WHO] World Health Organization (1978). Environmental Health Criteria, No. 6: Principles and Methods for Evaluating the Toxicity of Chemicals, World Health Organization, Geneva, 1, 25-61.
102. [WHO] World Health Organization (1990). Cancer: Causes, Occurrence and Control (L. Tomatis, ed.), IARC Scientific Publications, No. 100, Oxford University Press, New York, p. 59.
103. Williams, G. M., and J. H. Weisburger (1991). Chemical carcinogenesis. In Toxicology (M. O. Amdur, J. Doull, and C. D. Klaassen, eds.), Pergamon Press, New York, pp. 127-200.
104. Yamagiwa, K., and K. Ichikawa (1915). Experimentelle Studie über die Pathogenese der Epithelialgeschwülste, Mitt. Med. Fak. Univ. Tokio, 15, 295-344.
105. Yamagiwa, K., and K. Ichikawa (1918). Experimental study of the pathogenesis of carcinoma, J. Cancer Res., 3, 1-29.
106. Yamasaki, H., K. Enomoto, D. J. Fitzgerald, M. Mesnil, F. Katoh, M. Hollstein (1988). Role of intercellular communication in the control of critical gene expression during multistage carcinogenesis. In Cell Differentiation, Genes and Cancer (T. Kakunaga, T. Sugimura, L. Tomatis, and H. Yamasaki, eds.), IARC Scientific Publication 92, International Agency for Research on Cancer, Lyon, 57-75.